Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

S. Korea Set To Allow Resumption Of Embryonic Stem Cell Research

This article was originally published in PharmAsia News

Executive Summary

South Korean Health Ministry and biotech industry officials reportedly have agreed to resume allowing stem cell research using cloned embryonic cells. They agreed the National Bioethics Committee would allow such research as early as April. The panel had delayed that decision earlier because a hospital that wanted to do similar research had not resolved controversial ethics issues. South Korea banned such research three years ago when it was revealed groundbreaking studies in the area had been fabricated. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071020

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel